Introduction
The introduction of highly active antiretroviral therapy (HAART) in 1996 has led to a dramatic decline in human immunodeficiency virus type 1 (HIV-1)-associated mortality in developed countries. In those regions, liver-related morbidity is the most frequent non-AIDSrelated cause of deaths among HIV-1-infected patients partly because of the high rates of chronic viral hepatitis and alcohol misuse (Weber et al., 2006) . Interestingly, results from the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study indicate that there is a strong correlation between HIV-1-mediated immunosuppression and the risk of liver-related death, therefore suggesting that pathogenic mechanisms promoting T-cell depletion may also trigger liver injury by causing an impairment of liver immunity (Weber et al., 2006) .
The liver is an anatomically and immunologically unique organ where the blood from the systemic circulation and the gastrointestinal tract is filtered through hepatic sinusoids. The sinusoidal endothelium differs from the other capillaries in the body by the presence of numerous fenestrations and the lack of basal lamina under the endothelium (Wisse et al., 1985) . The small diameter of the sinusoids and the slow rate of blood flow prolong the contact between immune and endothelial cells (Wong et al., 1997) . This phenomenon, in addition to the special architecture of the fenestrated sinusoidal endothelium, facilitates extravasation of T lymphocytes through this organ (Warren et al., 2006) . The liver is constantly exposed to a variety of antigens derived from the gastrointestinal tract and systemic circulation, including dietary antigens, pathogens and toxins. Those antigens are efficiently sensed by a variety of innate immune cells residing in the liver, such as macrophages (better known as Kupffer cells), immature dendritic cells (iDCs), natural killer (NK) and NKT cells (Racanelli and Rehermann, 2006) . Although adaptive immune cells like CD4 + and CD8 + T lymphocytes can be found scattered in the portal tract, the most important pool of T lymphocytes interacting with liver cells originate from the bloodstream or the gastrointestinal tract (Shetty et al., 2008) . HIV-1 is known to productively infect CD4 + T cells in different ways. Increasing interest is focused on the cell-to-cell spreading that, for HIV-1, constitutes a more potent mode of virus propagation than following infection with cell-free virus (Dimitrov et al., 1993) . Several studies have demonstrated that cell-to-cell HIV-1 transmission can occur with the help of various carrier cells, including CD4-positive cells such as macrophages and iDCs (Carr et al., 1999; Geijtenbeek et al., 2000) , but also CD4-negative cells such as B lymphocytes (De Milito, 2004) , neutrophils, erythrocytes (Olinger et al., 2000) , epithelial (Asin et al., 2004; Giacaman et al., 2008; Meng et al., 2002; Mikulak et al., 2009 ) and endothelial cells (Thibault et al., 2007) . Obviously, productive infection of these carrier cells is not required for trans infection of susceptible target CD4 + T cells. Given their anatomical location and their role in acute HIV-1 infection, most of the trans infection studies have been done with iDCs. Although it has been proposed that DCs capture and internalize infectious viral particles by endocytosis to later deliver them to permissive cells via vesicular exocytosis, recent findings suggest that the majority of HIV-1 transmitted in trans originate from the plasma membrane (Cavrois et al., 2008 (Cavrois et al., , 2007 and more precisely from membrane invaginations (Yu et al., 2008) .
In the present work, we were interested in determining whether liver cells could, like the above-mentioned cell types (e.g. iDCS), contribute to trans infection of CD4 + T cells by HIV-1. Hepatocytes constitute about two thirds of the total cell population in the liver, where they are involved in many biological processes. To favour exchange with the blood, hepatocytes bear multiple surface microvilli. During viremic phases of HIV-1 infection, hepatocytes are expected to be frequently exposed to very large quantities of virus through the hepatic blood flow. Unfortunately, very few published studies can be found in the literature that relate to the possible interaction between HIV-1 and hepatocytes. Two previous works have described by in situ hybridization the presence of HIV-1 RNA and proteins in hepatocytes from liver biopsies of HIV-1-infected patients (Cao et al., 1992; Housset et al., 1993) . Since hepatocytes are negative for CD4, the primary cellular receptor for HIV-1, and express a barely detectable level of coreceptors CXCR4 and CCR5 (unpublished data), it is thus not surprising to observe that this cell type is weakly susceptible to productive infection with this retrovirus (manuscript in preparation). However, like epithelial cells (Bomsel and Alfsen, 2003) , hepatocytes could express other cell surface molecules promoting HIV-1 capture. Therefore, we hypothesized that interactions between virus and hepatocytes could contribute to HIV-1 pathogenesis by facilitating CD4 + T cells infection during their passage into the liver. In this study,
we first investigated the ability of human hepatoma cells to absorb and internalize HIV-1 particles. Next, we studied whether those viral particles can be efficiently transmitted to CD4 + T cells, and characterized the mechanism underlying the phenomenon.
Results
HIV-1 particles are captured and internalized inside human hepatoma cells, and persist therein for up to 3 days
We first set out to determine whether hepatocytes can capture virions which will ultimately remain infectious for a subsequent transfer toward susceptible target cells. For this purpose, we first evaluated if the human hepatoma Huh7.5 cells were able to bind and internalize X4-(i.e. NL4-3) and R5-tropic variants (i.e. NL4-3Balenv). For the binding assay, viral exposure was performed for varying time lengths at 4°C to prevent endocytosis of viral particles. Treatment of cells with pronase after viral binding at 4°C confirmed that HIV-1 is unable to enter inside hepatocytes at this temperature (data not shown). The possible internalization of HIV-1 within Huh7.5 was evaluated using an incubation step at 37°C followed by a trypsin proteolysis to remove uninternalized virus. As shown in Fig. 1A , human hepatoma cells can efficiently bind and internalize both X4-and R5-using virus in a time-dependent manner. A dose-dependent increase in virus attachment was seen when using escalating amounts of both NL4-3 (X4-using) and NL4-3Balenv virons (R5-tropic) (i.e. virus input of 5, 10, 20, 50 and 100 ng of p24) (data not shown). Additional experiments were performed also with an Env-deficient virus with similar results (data not shown), therefore indicating that the external Env glycoprotein 120 (gp120) was not necessary for virus binding and internalization in Huh7.5 cells.
Next we wanted to estimate how long viral particles can remain attached/internalized in hepatocytes before their degradation. To this end, a time-course study was carried out to evaluate the kinetics of HIV-1 degradation in hepatocytes by assessing the p24 content after removal of the unbound viruses by extensive washes with PBS to eliminate unadsorbed virions. Most of the viral degradation was observed during the first 4 h (Fig. 1B) . However, virus remains detectable for as long as 72 h. These results suggest that a certain amount of viral particles can remain associated with hepatocytes either at the cell surface or intracellularly for at least 3 days.
Hepatocyte-associated virus is efficiently transmitted to CD4 + T cells
Given that HIV-1 can be bound and internalized inside hepatocytes, our next step was to examine if such hepatocyte-associated virus can be efficiently transferred to susceptible CD4 + T cells. To answer this question, activated CD4 + T cells were exposed for 1 h at 37°C to HIV-1-pulsed hepatocytes as described in Materials and methods. Trans infection of permissive CD4 + T cells occurred when Huh7.5 cells were first exposed to X4 and R5 virions ( Fig. 2A ). An efficient hepatocyte-mediated transfer of HIV-1 was seen when using another human hepatoma cell line (i.e. HepG2) (data not shown).
Since hepatocyte-associated HIV-1 can persist for at least 72 h, we wondered whether those virions are still infectious and can be transmitted to susceptible CD4 + T cells. To answer this fundamental question, Huh7.5 cells were exposed to NL4-3 or NL4-3Balenv (30 ng of p24 per 1 × 10 5 cells) for 2 h at 37°C, washed twice with PBS and left at 37°C for the listed periods of time (i.e. from 0 to 72 h). In order to remove free virus released during the incubation time, hepatocytes were washed once with PBS before addition of activated CD4 + T cells.
Data depicted in Fig. 2B indicate that hepatocyte-associated NL4-3 and NL4-3Balenv remain infectious for 2 and 3 days, respectively. Taken together, our results suggest that human hepatocytes can trap HIV-1 particles, keeping them infectious for at least 48 h and transfer them to permissive CD4 + T cells.
Hepatocyte-mediated trans infection is more efficient than cell-free virus infection
We next evaluated whether transfer through hepatocytes results in stronger viral infection of CD4 + T cells than infection by cell-free virions, as it is known to be the case with macrophages (Carr et al., 1999) . To compare efficiency of trans infection (hepatocytes-associated virus) with that of direct infection (cell-free virus) of activated CD4 + T cells, the amount of hepatocyte-captured viruses available for trans infection, after 2 h of pulsing, was determined by the p24 assay. This same quantity was used to directly infect CD4 + T cells. As shown in Trans infection by hepatocytes is due to transmission of virus associated with the plasma membrane
As previously described for DCs, which is the typical cell type used to define trans infection process also known as the "Trojan horse" model, the virus involved in trans infection could originate either from plasma membrane or intracellular vesicles (Cameron et al., 1992; Geijtenbeek et al., 2000) . To discriminate between these two distinct origins, Cavrois et al. (2007) used sCD4, a virus-specific membrane-impermeable inhibitor, to neutralize viruses bound onto the plasma membrane without affecting those located inside intracellular compartments. A similar experimental procedure was used and results depicted in Fig. 4 demonstrate that a treatment with sCD4 is sufficient to prevent trans infection of CD4 + T cells by hepatocyte-associated virions. Importantly, the efficiency of sCD4 neutralization was similar for X4-and R5-tropic viruses (respectively 95 ± 3 and 97 ± 1 percent inhibition, calculated with data collected from 3 different donors and express as mean ± SEM). Altogether our findings demonstrate that virions transmitted in trans originate from the plasma membrane of Huh7.5 cells and not from intracellular vesicles.
ICAM-1/LFA-1 interactions are involved in hepatocyte-mediated trans infection of CD4 + T cells
Cell-to-cell interactions mediated by intercellular adhesion molecule-1 (ICAM-1) and leukocyte function-associated molecule-1 (LFA-1) have been proposed to be important for HIV-1 transmission from DCs (Wang et al., 2009 ) or CD4-negative cells (Olinger et al., 2000) . The possible involvement of ICAMs/LFA-1 interactions in the hepatocytemediated transfer of HIV-1 was thus investigated by first assessing surface expression of ICAM molecules in Huh7.5 cells by flow cytometry. We observed that these cells express high levels of ICAM-1 but are negative for both ICAM-2 and -3 (Fig. 5A) . However, as expected, Huh7.5 cells do not express LFA-1 (data not shown). Next, activated CD4 + T cells were incubated with a neutralizing monoclonal antibody against LFA-1 (i.e. MEM-25) before performing a trans infection experiment as described above. As shown in Fig. 5B , the presence of the blocking anti-LFA1 antibody before initiation of the co-culture step resulted in a marked diminution in the hepatocyte-dependent transmission of HIV-1 toward CD4 + T cells (i.e. 83± 9% inhibition, calculated with data collected from 3 different donors and express as mean± SEM), whereas the isotype-matched control antibody (i.e. IgG 1 ) displayed no inhibitory effect. To ensure the validity of these data, similar studies were conducted with another inhibitor, namely the LFA-1 antagonist XVA143 as described recently (Tardif et al., 2009) . A strong reduction in hepatocyte-mediated HIV-1 trans infection of CD4 + T cells was seen with XVA143 (i.e. 71 ± 6% inhibition, calculated with data collected from 3 different donors and express as mean± SEM) (Fig. 5C ). This inhibition was dose-dependent when using concentrations ranging from 0.05 to 5 μM (data not shown). The vehicle (DMSO), used here as a control, has no effect on trans infection. It is important to note that MEM-25 and XVA143 were removed after the contact between HIV-1-loaded hepatocytes and CD4 + T cells to allow cell-to-cell virus spreading. Homotypic aggregation of activated CD4 + T cells when cultured alone confirmed that the studied inhibitors had been effectively removed and that the observed effect was not caused by hindering cell-to-cell contacts (data not shown).
Discussion
Knowing that the liver filters an average of 2,600 liters of blood daily that contain about 10 8 peripheral blood lymphocytes (Wick et al., 2002) and given that hepatocytes constitute two thirds of the total liver cell population, it can be proposed that hepatic cells are most likely exposed to significant amounts of circulating virus in the context of an HIV-1 infection and may therefore contribute to some extent to the disease pathogenesis by transmitting virions to permissive CD4 + T cells circulating through the liver in both normal and inflammatory conditions. Our in vitro studies support this postulate since we report here that human hepatoma cell lines can first capture and internalize X4-and R5-tropic isolates of HIV-1 and or treated for 30 min at 37°C with the blocking anti-LFA-1 monoclonal antibody MEM-25 (2.5 μg/ml) (B) or the LFA-1 antagonist XVA143 (0.5 μM) (C) before initiating a co-culture step with virus-pulsed Huh7.5 cells. Next, CD4 + T cells were removed and cultured alone. Virus production was monitored at several dpi. Data shown represent the mean ± SEM of quadruplicate samples from a single donor at 2 dpi and are representative of 3 different donors. The kinetics of virus production over time is displayed in small inserts. Statistical analysis was performed on the results from all experiments. Asterisks denote statistically significant difference (⁎p b 0.05).
next transmit infectious particles to susceptible CD4 + T cells. In addition, we provide evidence that acute infection of CD4 + T cells with hepatocyte-associated virus is two orders of magnitude more efficient than infection with cell-free virus. Although hepatocytes can internalize HIV-1 particles, a minority seems to be transferred from an internal compartment. In fact, trans infection of CD4 + T cells with both X4 and R5 virus is significantly inhibited by a treatment with sCD4 suggesting that the vast majority of the transmitted virus originates from the plasma membrane. This raised the issue of the mode of attachment of HIV-1 particles onto hepatocytes, which may be multifactorial. The absence of detectable expression of CD4 coupled with low levels of CXCR4 and CCR5 expression on the surface of Huh7.5 cells suggest that viral binding and internalization could be independent of gp120. This possibility was confirmed when using an Env-deficient virus. Moreover unpublished observations suggest that adsorption of viral particles may be mostly caused by electrostatic or other undefined interactions (data not shown). Our findings also suggest that host proteins, lipids or polysaccharides incorporated in the viral bilayer might participate in viral adsorption on the hepatocyte cell surface. One possibility is that glycosphingolipids anchored into the viral membrane could play a role in the attachment process via factors recognizing those molecules on hepatocytes. In fact, it has been recently described that, in absence of Env glycoproteins, HIV-1-associated glycosphingolipids participate in the initial DC-mediated HIV-1 capture (Hatch et al., 2009) . Further investigations are required to shed light on the precise mechanism(s) by which hepatocytes can capture HIV-1 particles and keep them infectious for an extended time length.
Depending on the nature of attachment factors mediating HIV-1 binding, the interaction between viruses and hepatocytes can lead to either viral degradation or viral protection, the latter one permitting the subsequent trans infection of CD4 + T cells. In the current study, we demonstrate that hepatocyte-associated virus can remain infectious for at least 2 or 3 days suggesting that hepatocytes could represent a transient HIV-1 reservoir. A number of hypotheses can be proposed to explain how HIV-1 particles can remain infectious for a long period of time while being associated with the plasma membrane of hepatocytes. It is possible that HIV-1 particles remain associated within deep invaginations, protected from the surrounding environment, and that, upon a physical contact with CD4 + T cells, virions are redistributed at the cell-to-cell interface. Alternatively, viruses could travel along the length of filopodia, which are thin actin-rich cellular extensions functioning as antennae to sense the environment, to communicate with other cells and to initiate cell-cell or cell-matrix adhesion (Mattila and Lappalainen, 2008) . This phenomenon has already been described for retroviruses, including HIV-1 (Hope, 2007; Sherer and Mothes, 2008) . Moreover, in non-inflamed states the interaction between hepatocytes and CD4 + T cells can occur through fenestrations present in the sinusoidal endothelium. It has been demonstrated, at least in murine liver, that cytoplasmic extensions of hepatocytes can cross the fenestrations and contact circulating T cells (Warren et al., 2006) . Alternatively, membrane extensions from circulating T lymphocytes can pass through the fenestrations and reach plasma membrane of hepatocytes. In some particular conditions affecting the integrity of the fenestrated sinusoidal liver endothelium (Braet and Wisse, 2002) , the contact between hepatocytes and T lymphocytes might be facilitated, notably during liver infection, alcohol-induced cirrhosis, or microbial translocation triggering endotoxin exposure (Braet and Wisse, 2002) . In any case, further studies are required to clarify where HIV-1 particles are precisely localized on hepatocytes.
In other respects, we report that ICAM-1/LFA-1 interactions play a dominant role in the transmission of HIV-1 from hepatocytes. Although hepatocytes in normal tissues express low or undetectable levels of ICAM-1, as detected by immunohistochemistry (Adams et al., 1991; Dustin et al., 1986) , it has been reported that proinflammatory cytokines and endotoxin stimulate ICAM-1 expression in hepatocytes (Satoh et al., 1994) . Given that HIV-1 infection is characterized by a heightened inflammatory state, it can be proposed that hepatocytes in HIV-1-positive individuals do express ICAM-1. Interestingly, expression of ICAM-1 is polarized toward sinusoidal lumen in murine liver (Warren et al., 2006) . It can thus be postulated that the initial contact between these cells and T lymphocytes mostly depends on ICAM-1 and its counterreceptor on T cells, the integrin LFA-1. This adhesive interaction plays important roles in immunity by stabilizing the association between antigen-presenting cells and T lymphocytes and also by mediating leukocytes migration. Moreover, the LFA-1-mediated cell-to-cell adhesion process has been proposed to be important for HIV-1 transmission from DCs (Sanders et al., 2002; Wang et al., 2009 ) as well as from CD4-negative cells (Olinger et al., 2000) to CD4 + T cells promoting the formation of an infectious synapse (Martin and Sattentau, 2009 ). Here we show that the ICAM/LFA-1 interaction plays a dominant role in the hepatocyte-mediated HIV-1 transfer toward activated CD4 + T cells. Indeed, blocking LFA-1 on activated CD4 + T cells either with a neutralizing monoclonal antibody or a specific antagonist strongly impairs the hepatocytemediated HIV-1 transmission.
In this study, we present for the first time a process by which circulating CD4 + T cell can be infected with HIV-1 in the largest organ inside the body, i.e. the liver. Indeed, our data indicate that hepatocytes can capture and internalize X4-and R5-tropic strains of HIV-1, and mediate trans infection of CD4 + T cells. Moreover, the capacity of hepatic cells to serve as a transient reservoir for HIV-1 can also affect NKT cells, another lymphocyte subpopulation known to be enriched in the liver. Importantly, this T cell subset was previously identified as susceptible to productive HIV-1 infection (Motsinger et al., 2002) . Three independent studies convincingly showed that HIV-1 infection causes a significant reduction in NKT levels at a rate faster than that of conventional CD4 + T cells (Motsinger et al., 2002; Sanders et al., 2002; van der Vliet et al., 2002) . Knowing that NKT cells play an important role in acute HCV infection (Golden-Mason et al., 2007) , we hypothesize that hepatic NKT cell depletion mediated by hepatocyte-associated HIV-1 trans infection may increase susceptibility to HCV infection. Altogether, those phenomena could explain why individuals diagnosed with primary HIV-1 infection present a higher incidence of acute HCV infection (Fox et al., 2008; Osinusi et al., 2009 ). Finally, our results suggest that hepatocytes play a previously unrecognized role in HIV-1 replication in CD4 + T cells and viral pathogenesis through a trapping mechanism.
Conclusions
In summary, this work describes for the first time an interesting mechanism by which circulating CD4 + T cell can be infected with HIV-1 in the liver. We demonstrate that hepatocytes are able to bind and internalize HIV-1 particles and transmit cell surface-associated virus to CD4 + T cells through ICAM-1/LFA-1 interactions. This cell-to-cell infection process might facilitate viral dissemination throughout the organism. This study highlights the need to investigate more deeply the role of the liver in HIV-1 infection and to study more closely co-infection with pathogens that can target this vital organ (e.g. HCV and HBV).
Materials and methods

Cells
Human hepatoma cell lines Huh7.5 (supplied by C.M. Rice, Apath LLC, St Louis, MO) and HepG2 (a kind gift from L. Bélanger, Centre de recherche de l'Hôtel-Dieu de Québec, Québec, QC) were maintained as monolayers in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated foetal bovine serum (FBS), streptomycin (100 μg/ml), penicillin G (100 U/ml) and 0.1 mM of non-essential amino acids (Invitrogen, Burlington, ON). Human embryonic kidney 293T cells (ATCC, Manassas, VA) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated FBS, streptomycin (100 μg/ml), penicillin G (100 U/ml). Human primary CD4 + T cells from healthy donors were isolated using a negative selection kit according to the manufacturer's instructions (StemCell Technologies Inc., Vancouver, BC). Purified CD4 + T cells were cultured in RPMI-1640 medium (Invitrogen) supplemented with 10% FBS, streptomycin (100 μg/ml), penicillin G (100 U/ml) and were stimulated for 2 days with the mitogenic agent phytohemagglutinin-L (PHA-L) (1 μg/ml) and recombinant human interleukin-2 (rhIL-2) (30 U/ml) prior to their use in co-culture studies with virus-loaded Huh7.5 cells.
Reagents and antibodies
The anti-CD11a monoclonal antibody (mAb) (clone MEM-25) was purchased from Axxora (San Diego, CA). Anti-ICAM-2 (clone 92C12F) and anti-ICAM-3 (ICR-5.1) mAbs were supplied by ICOS Corp. (Bothell, WA) while the anti-ICAM-1 Ab RR1/1.1.1 was kindly provided by Robert Rothlein (Boehringer Ingelheim, Ridgefield, CT) . Hybridomas producing 183-H12-5C and 31-90-25, two mAbs recognizing different epitopes of the HIV-1 major viral core protein p24, were supplied by the AIDS Repository Reagent Program (Germantown, MD) and ATCC, respectively. Antibodies obtained from these cells were purified using mAbTrap protein G affinity columns according to the manufacturer's instructions (Amersham Pharmacia Biotech, Piscataway, NJ). PHA-L was obtained from Sigma (St-Louis, MO) and rhIL-2 as well as soluble CD4 (sCD4) were kindly supplied by the AIDS Repository Reagent Program. The LFA-1 antagonist XVA143 was kindly donated by Paul Gillespie (Hoffmann-La Roche Inc., Nutley, NJ).
Plasmids and production of viral stocks
Plasmids used to produce viral stocks include pNL4-3 (Adachi et al., 1986 ) and pNL4-3Balenv (Dornadula et al., 1999) , two fulllength infectious molecular clones of HIV-1. In pNL43Balenv, the env gene of the X4 (T)-tropic NL4-3 strain has been replaced with that of the R5 (macrophage)-tropic Bal strain. The NL4-3Δenv vector encodes a complete HIV-1 genome containing a -1 frameshift in the envelope (Env) precursor and was used to produce Env-deficient viruses (kindly provided by David E. Ott from the National Cancer Institute, Frederick, MD). Virions were produced by transient transfection in 293T cells as previously described (Fortin et al., 1997) . The viruscontaining supernatants were filtered through a 0.22-μm cellulose acetate syringe filter, ultracentrifuged in an Optima L-90K Beckman Coulter apparatus (Fullerton, CA) for 45 min at 28,000 rpm (100,000g) in a 70 Ti rotor and normalized for virion content using a sensitive inhouse ELISA specific for the viral p24 protein. In this enzymatic assay, 183-H12-5C and 31-90-25 antibodies are used in combination to quantify p24 levels (Bounou et al., 2002) .
Virus binding and internalization experiments
Huh7.5 cells were exposed to NL4-3 or NL4-3Balenv (10 ng of p24 per 1 × 10 5 cells) for 0-4 h at 4°C (to test virus binding) or 37°C (to test virus internalization). For assessing the level of virus binding, the cells were washed 3 times with ice-cold phosphate-buffered saline (PBS) in order to remove free virions. To demonstrate that only virus binding is taking place at 4°C, the cells were subjected to a pronase treatment (i.e. 200 μg/ml for 30 min at 4°C) following incubation with HIV-1 as described previously (Cavrois et al., 2007) . For virus internalization, the cells were washed once with ice-cold PBS, treated with 0.05% trypsin and 0.53 mM EDTA (Invitrogen) for 5 min at 37°C (proteolysis was stopped by adding an equal volume of FBS), to remove all noninternalized viral particles, and washed twice with ice-cold PBS. Finally, cells were lysed in 100 μl of lysis buffer (20 mM HEPES [pH 7.4], 150 mM NaCl, and 0.5% Triton X-100). The amount of attached or internalized virus was estimated by assessing the p24 content.
Virus degradation experiments
Huh7.5 cells were exposed to NL4-3 or NL4-3Balenv (30 ng of p24 per 1 × 10 5 cells) for 2 h at 37°C, washed twice with PBS and left at 37°C for various time periods ranging from 0 to 72 h. Cells were then washed once with PBS and lysed in 200 μl of lysis buffer. The amount of virus was estimated by the p24 assay.
Trans infection experiments
Adherent Huh7.5 cells or HepG2 cells (1 × 10 5 in 48-well flatbottom tissue culture plates) were pulsed with studied virus stocks (30 ng of p24) for 2 h at 37°C. Cells were then washed 3 times with ice-cold PBS to remove unbound virions and activated CD4 + T lymphocytes were incubated together with virus-pulsed Huh7.5 cells (3:1 ratio) for 1 h at 37°C. Next, non-adherent CD4 + T lymphocytes were removed from adherent Huh7.5 cells through the use of 5 mM EDTA-PBS to disrupt cell-to-cell interactions, washed twice with PBS and then cultured in complete RPMI-1640 medium supplemented with rhIL-2 (30 U/ml). Cell-free supernatants (half of the medium) were harvested at days 2, 4 or 6 following trans infection and kept frozen at −20°C. Virus production was estimated by measuring p24 levels in such cell-free culture supernatants.
To assess infectivity of virus located on the surface of hepatocytes, Huh7.5 cells were pulsed as described above and left at 37°C for increasing time periods (i.e. from 0 to 72 h) before being used to trans infect mitogen-activated CD4 + T lymphocytes. Cell-free supernatants (half of the medium) were harvested at days 2, 4, 6, 8, 11 or 15 following trans infection and kept frozen at −20°C until p24 quantification. For localizing virus in hepatocytes that trans infect permissive CD4 + T cells, experiments were performed as described above, with the following additional step. After virus pulsing, HIV-1-loaded Huh7.5 cells were treated with 20 μg/ml of soluble CD4 (sCD4) for 60 min at 4°C in order to neutralized surface bound virus. For monitoring the contribution of ICAM-1/LFA-1 interactions to the hepatocyte-mediated virus transfer process, trans infection studies were performed as described above, with the following additional step. The blocking anti-LFA-1 monoclonal antibody MEM-25 or the LFA-1 antagonist XVA143 were added to CD4 + T cells for 30 min before incubation with HIV-1-loaded Huh7.5 cells.
Comparative studies between hepatocyte-mediated trans infection and cell-free virus infection of CD4 + T cells
To compare efficiency of trans (virus-loaded hepatocytes) and direct (cell-free virus) infection of CD4 + T cells, the amount of hepatocyteassociated virus after 2 h of pulsing was determined by the p24 assay. This quantity (approximately 3 ng of p24) was used to achieve infection of CD4 + T cells with cell-free virus (3 × 10 5 in 200 μl of culture medium)
for 1 h at 37°C. As for trans infection, CD4 + T cells were then washed with PBS and cultured in complete RPMI-1640 medium supplemented with rhIL-2 (30 U/ml). Cell-free supernatants (half of the medium) were harvested at days 2, 4 or 6 following trans infection and kept frozen at −20°C. Virus production was estimated by measuring p24 levels in such culture supernatants.
Flow cytometry
Subconfluent Huh7.5 cells were removed by a treatment with 5 mM EDTA-PBS before performing flow cytometry analyses. Cells (1 × 10 6 ) were incubated with 100 μl of 10% FBS-PBS containing a saturating amount of a monoclonal anti-ICAM-1, anti-ICAM-2, anti-ICAM-3 or an appropriate isotype-matched irrelevant control mAb (for non-specific staining) for 30 min on ice. Cells were next washed with PBS and then incubated, when appropriate, with 100 μl of a saturating amount of R-PE-conjugated goat anti-mouse immunoglobulin G (Invitrogen) for 30 min on ice. After two washes with PBS, cells were fixed in 2% paraformaldehyde and analyzed with a cytofluorometer (EPICS XL, Coulter Corp., Miami, FL).
Statistical analysis
Analysis was performed by one-way analysis of variance or matched-pair t test. P values of less than 0.05 were considered to be statistically significant. Computations were carried out using GraphPad PRISM ® version 3.03 statistical software.
